cutiss.swiss

Cutiss Ag


CUTISS AG can now bio-engineer large quantities of individually customized human skin grafts, denovoSkin™, starting off from a very small piece of healthy patient’s skin. Because of its intrinsic characteristics, denovoSkin™ is expected to result in a minimally scarring outcome after transplantation. denovoSkin™ received a Swissmedic, EMA and FDA Orphan drug designation for the treatment of burns.
View Top Employees for Cutiss Ag
img Website cutiss.swiss
img Industry Biotechnology
img Location Zurich, Switzerland
img Employees 26
img Founded 2017
img HQ Weinbergstrasse 35,
img Funding 28,267,671 USD
img Competitors Roche, Agilent Technologies, Amgen, Genentech, Eurofins, Gilead Sciences,
img Website cutiss.swiss
img Industry Biotechnology
img Location Zurich, Switzerland
img Employees 26
img Founded 2017
img LinkedIn linkedin.com/company/cutiss-ag
img HQ Weinbergstrasse 35,
img Funding 28,267,671 USD

Top Cutiss Ag Employees